Donati et al. discovered that an additional polymorphism in the PNPLA3 gene, rs2294918 G > A encoding the E434K protein variant, ameliorated the effect of PNPLA3-I134M on development of NASH by reducing its expression [57]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.